Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster session 08

2267P - Coronary heart disease and risk of lung cancer: A two-sample Mendelian randomization study

Date

21 Oct 2023

Session

Poster session 08

Topics

Translational Research

Tumour Site

Non-Small Cell Lung Cancer

Presenters

Cai Chen Li

Citation

Annals of Oncology (2023) 34 (suppl_2): S1152-S1189. 10.1016/S0923-7534(23)01927-0

Authors

C.C. Li1, Q. Cai1, L. Lin1, J. Li2, J. He3, W. Liang4

Author affiliations

  • 1 Thoracic Oncology Dept., Guangzhou Medical University, 510000 - Guangzhou/CN
  • 2 Thoracic Oncology Dept., State Key Laboratory of Respiratory Diseases - The First Affiliated Hospital Of Guangzhou Medical University, 510120 - Guangzhou/CN
  • 3 Thoracic Surgery Department, The First Affiliated Hospital of Guangzhou Medical University, 510120 - Guangzhou/CN
  • 4 Thoracic Oncology Dept., The First Affiliated Hospital of Guangzhou Medical University, 510120 - Guangzhou/CN

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 2267P

Background

Observational studies have suggested an association between coronary heart disease and increased risk of lung cancer, but the causal relationship between these two conditions remains uncertain. Therefore, we conducted a two-sample Mendelian randomization study to investigate whether there is a causal relationship between coronary heart disease and higher risk of lung cancer.

Methods

We utilized 37 single nucleotide polymorphisms (SNPs) associated with coronary heart disease (with a p-value <5x10-8) from a genome-wide association study involving 184,305 European individuals in the CARDIoGRAMplusC4D Consortium as instrumental variables. Summary data for lung cancer were obtained from the International Lung Cancer Consortium, including 11,348 cases and 15,861 controls. We conducted primary MR analysis using the inverse-variance weighted method and evaluated the MR assumptions in sensitivity analyses. Subgroup analyses were performed for different histological subtypes of lung cancer, and all analyses were carried out using the TwoSampleMR package in R.

Results

The MR analysis revealed that a genetic predisposition to coronary heart disease had a protective effect against the development of lung cancer, with an odds ratio (OR) of 0.88 (95% confidence interval [CI] 0.78-0.99, P=0.035). Subgroup analyses indicated a decreased risk for squamous cell lung cancer (OR 0.80, 95% CI 0.68-0.93, P=0.004), but no significant association was observed in lung adenocarcinoma (OR = 0.87; 95% CI 0.73-1.03, P=0.106). Sensitivity analyses supported a causal interpretation of the findings, indicating that major bias from genetic pleiotropy was unlikely.

Conclusions

Contrary to findings from previous observational studies, our results suggest that coronary heart disease may have a protective effect against the development of lung cancer. These findings emphasize the need to further investigate the underlying mechanisms linking these two conditions and provide a foundation for future research in this field.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

Caichen Li.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.